Skip to content

Role of BCG vaccination on innate immunity

Role of BCG vaccination on innate immunity - BCGvac1

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57700
Enrollment
20
Registered
2010-06-10
Start date
2010-05-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immune system innate immunity

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: healthy human volunteers who are scheduled to have a BCG vaccination, 18 - 55 yr old

Exclusion criteria

Exclusion criteria: Subjects should not come from a Mycobacterium tuberculosis endemic country and are not allowed to use any medication except oral anticonception drugs

Design outcomes

Primary

MeasureTime frame
The following parameters are compared before and after vaccination: cytokine production, phenotype of immune cell population, C. albicans phagocytosis and killing, mRNA expression of signaling pathway molecules.

Secondary

MeasureTime frame
Polymorphisms of genes important for innate immune responses will be analyzed and correlated with innate immunity function

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)